Pivotal Study to Assess the Safety and Effectiveness of the iTind Device
Public ClinicalTrials.gov record NCT02506465. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multi-center Prospective Study to Assess the Safety and Effectiveness of Medi-Tate i-Temporary Implantable Nitinol Device (iTind) in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study objectives are to demonstrate the efficacy and safety of the Medi-Tate iTIND as compared to control group (catheter only).
Study identification
- NCT ID
- NCT02506465
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 185 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years to 80 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2015
- Primary completion
- Sep 30, 2018
- Completion
- Sep 30, 2018
- Last update posted
- Feb 27, 2022
2015 – 2018
United States locations
- U.S. sites
- 11
- U.S. states
- 4
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Center of Florida | Pompano Beach | Florida | 33060 | — |
| Chesapeake Urology Research Associates | Baltimore | Maryland | 21209 | — |
| Methodist Hospital | Brooklyn | New York | 11215 | — |
| Winthrop University | Garden City | New York | 11501 | — |
| St John's Episcopal | Lawrence | New York | 11691 | — |
| Integrated Medical Professionals | Long Island City | New York | 11735 | — |
| Manhattan Medical research | Manhattan | New York | 10016 | — |
| Weill cornell | Manhattan | New York | 10065 | — |
| Premier Urology Group | New York | New York | 08857 | — |
| Primier Medical Center | Poughkeepsie | New York | 12601 | — |
| Carolina Uro Research Center | Myrtle Beach | South Carolina | 29572 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02506465, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 27, 2022 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02506465 live on ClinicalTrials.gov.